Abstract. Simple, rapid and sensitive methods are described for the spectrophotometric determination of citalopram hydrobromide (CIT) in pharmaceuticals. The method A is based on the oxidation of citalopram by a known excess of bromate-bromide mixture in hydrochloric acid medium, reduction of the residual oxidant by a fixed amount of iron(II) and the formation of iron(III)-thiocyanate-complex which is measured at 480 nm. In the method B, 1,10-phenanthroline is used as a complexing agent and the formation of iron(II)-1,10-phenanthroline, which is measured at 510 nm. The system obeys Beer's law in the concentration range of 1.0-7.0 µg mL -1 of CIT for method A and 0.6-6.2 µg mL -1 of CIT for method B. No interference observed from common pharmaceutical adjuvants. Both methods are equally precise as shown by the relative standard deviation values less than 2%. The apparent molar absorptivities and Sandell's sensitivity for method A and B are found to be 2.10 × 10 4 L mol -1 cm -1 , 0.019 µg cm -2 , 7.30 × 10 4 L mol -1 cm -1 and 5.5 × 10 -3 µg cm -2 , respectively. The methods have been successfully applied to the determination of citalopram hydrobromide in pure and dosage forms.
Introduction
Citalopram is a selective and potent serotonin reuptake inhibitor with a very broad spectrum of therapeutic activity against depression, anxiety, obsessive and impulse control disorders [1, 2] . Citalopram is a Pgp substrate and is actively transported by that protein from the brain. The efficiency of citalopram in people possessing a certain version of Pgp (genetic TT-allele) is likely to be diminished. This suggests that in non-responders to citalopram a switch to antidepressant which is not a Pgp substrate, such as fluoxetine (Prozac, Fontex) or mirtazapine (Remeron)-but not to venlafaxine (Effexor), amitriptyline (Elavil) or paroxetine (Paxil), which are Pgp substrates-may be beneficial [3] . Distinct from some other agents in its class, citalopram exhibits linear pharmacokinetics and minimal drug interaction potential, making it a better choice for the elderly or comorbid patients [4] .
Citalopram should be taken with caution when using St John's wort, as resulting drug interactions could be adverse [5] . This may be caused by compounds in the plant extract reducing the efficacy of the hepatic cytochrome P450 enzymes that process citalopram. It has also been suggested that such compounds, including hypericin, hyperforin and flavonoids, could have SSRI-mimetic effects on the nervous system, although this is still subject to debate [6] . One study found that hypericum extracts had similar effects in treating moderate depression as citalopram, with fewer side effects [7] . Several analytical methods have been reported for the determination of citalopram [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
The development of new methods capable of determining drug concentration in pharmaceutical formulations and biological samples is important. The low cost and ease of operation make the spectrophotometric method highly desirable alternative for the assay of citalopram hydrobromide. Hence simple, sensitive and selective methods for the determination of citalopram hydrobromide have been developed and validat-ed according to ICH guidelines. The method is more sensitive than the existing methods and are free from such experimental variables such as heating or extraction step. The method rely on the use of simple, cheap chemicals and techniques but provide sensitivity comparable to that achieved by sophisticated and expensive technique like HPLC. Statistical analysis of the results indicates that the method yields exact values. Hence the proposed method has been successfully applied to the determination of citalopram in pharmaceutical samples.
Results and Discussion
In this method bromate in acid medium acts as an oxidizing agent and there is the formation of nascent oxygen. The formed nascent oxygen oxidizes bromide to bromine and the in situ generated bromine oxidizes the drug. The unreacted bromine is determined by two different scheme. The reduction of residual oxidant by iron(II) resulting in the formation of iron(III). In method A, resulting iron(III) is complexed with thiocyanate and measured at 480 nm ( Figure 1 ). In method B, unreacted bromine is treated with a measured excess of iron(II) and remaining iron(II) is complexed with 1,10 phenanthroline and measured at 510 nm ( Figure 2 ). Preliminary experiments were performed to fix the reagent concentration. In the present method all parameters influencing the color development were investigated and are incorporated in the recommended procedure.
In method A, citalopram when added in increasing concentration to a fixed concentration of bromate-bromide mixture, there was a decrease in the concentration of bromatebromide mixture. When known volume of Fe(II) was added to the same mixture, unreacted oxidant was reduced by a fixed amount of iron(II) and it showed a proportional decrease in the concentration of iron(III). The result could be observed by decrease in the absorbance with the increase in the concentration of citalopram at the respective l max. In method B, citalopram when added in increasing concentration to a fixed concentration of bromate-bromide mixture, there was a decrease in the concentration of bromate-bromide mixture. When the decreasing amount of oxidant are reacted with a fixed amount of iron(II), it showed a proportional increase in the concentration of iron(II). As a result there is a proportional increase in the absorbance with the increasing concentration of the drug. Hydrochloric acid medium was found to be ideal for both the steps in method A and B, addition of excess of acid are not preferable since they would require large quantities of ammonia to raise the pH to 4, required for iron(II)-phenanthroline complex formation.
Analytical Data
Adherence to Beer's law was studied by measuring the absorbance values of solutions varying in drug concentration. The analytical parameters such as molar absorptivity, Sandell's sensitivity, detection limit, quantitation limit, slope, intercept, correlation coefficients for method A and method B are incorporated in table 1. The calibration graphs are described by the equation: Y = a + b X (where Y = absorbance, a = intercept, b = slope and X = concentration in mgml -1 ) obtained by the method of least squares.
Accuracy and Precision
The accuracy and precision of the method was established by analyzing the pure drug solution at 5 different levels (within working limits). The results are summarized in table 3 and 4.
Interference Study
In pharmaceutical analysis, it is important to test the selectivity towards the excipients added to the pharmaceutical preparations. Commonly encountered excipients such as glucose, Badiadka Narayana and Kunnummel Veena
Conclusions
Simple, sensitive and selective spectrophotometric methods for the determination of citalopram hydrobromide have been developed and validated according to ICH guidelines. The developed methods have the advantage of sensitivity compared with the existing method in the literature [22] . The methods are easy to perform and do not contain any stringent experimental variables which effect the reliability of the results. There is no interference from common additives and excipients. The methods thus can be used in the determination of CIT in pure and dosage forms
Experimental Apparatus
A Shimadzu UV-2550 UV-VIS Spectrophotometer with 1 cm matched quartz cells were used for the absorbance measurements.
Reagents and Solutions
All reagents used were of analytical reagent grade and distilled water was used for the preparation of all solutions. A 1000 
Applications
The proposed methods have been applied to the determination of citalopram in tablets. The results for the tablets were compared statistically with those of the tabulated value at 95% confidence level. The calculated student's t-test did not exceed the tabulated value. Table 2 gives the results of the determination from which it is clear that there is close agreement between the results obtained by the proposed methods and label claim. The parameters showing the sensitivity of the method such as molar absorptivity, Sandell's sensitivity were found to be higher compared with the existing method in the literature [22] . The low values of the relative standard deviation in percentages and the error indicated the high accuracy of the two methods.
µg mL -1 standard drug solution of CIT was prepared in 50% ethanol and made up to the mark with distilled water and the stock solution was diluted appropriately to get the working concentration. Purity of the citalopram hydrobromide is found to be 99.51% (a gift sample from CAD Pharma Inc, India). Bromate-bromide mixture (30 and 50 µg mL -1 in KBrO 3 ), ferrous ammonium sulphate (400 and 350 ìg mL -1 ), 1,10 phenanthroline (0.3%), ammonia (1:1), thiocyanate (1M) were used.
Spectrophotometric Method A
Aliquots containing 1.0-7.0 µg mL -1 of CIT were transferred into a series of 10 mL standard flasks using a micro burette. To this, 1 mL of 5 mol L -1 HCl and bromate-bromide mixture (30 µg mL -1 in KBrO 3 ) were added. The contents were shaken well and were set aside for 5 min with occasional shaking. Then, 1 mL of 400 µg mL -1 ferrous ammonium sulphate was added and again the flask let stand for 15 min with occasional shaking followed by 3.5 mL of ammonium thiocyanate was added and diluted to the mark with distilled water, the absorbance of each solution was measured at 480 nm against the reagent blank.
Spectrophotometric Method B
Aliquots containing 0.6-6.2 µg mL -1 of CIT were transferred into a series of 10 mL standard flasks using a micro burette. To this, 1 mL of 5 mol L -1 HCl and bromate-bromide mixture (50 µg mL -1 in KBrO 3 ) were added. The contents were shaken well and were set aside for 5 min with occasional shaking. Then, 1 mL of 350 µg mL -1 ferrous ammonium sulphate was added and again the flask let stand for 15 min with occasional shaking followed by 1 mL each of 0.3% 1,10 phenanthroline and 1:1 NH 3 solution were added and diluted to the mark with distilled water, and the absorbance of each solution was measured at 510 nm against the reagent blank.
Analysis of Dosage Forms
To determine the content of citalopram in conventional tablets (label claim: 20 mg/ tablet), the sample stock solution was prepared by taking five tablets of citalopram equivalent to 100 mg were powdered using a mortar and pestle and transferring to a 100 mL volumetric flask by washing with ethanol. The solution was shaken for 30 min and filtered through Whatman no.1 filter paper and the clear solution was made up to 100 mL. Pipetted out (2 mL for method A and 0.6 mL for method B) in to a 10 mL calibrated flasks, subjected to analysis by the proposed methods. The results are listed in table 2. 
